[与阿尔茨海默氏症相关的与年龄相关的黄斑变性相关的氨基化和神经营养障碍]
1Volgograd State Medical University, Volgograd, Russia.
Arkhiv patologii
|December 2, 2025
概括
粉样蛋白沉积和神经营养功能障碍是与老年相关的疾病的关键,如阿尔茨海默氏症和与年龄相关的黄斑变性. 针对这些途径可能会改善神经退行性和眼科疾病的治疗方法.
科学领域:
- 眼科医生 眼科 眼科
- 神经学 神经学
- 病理学 病理学 病理学
背景情况:
- 粉样蛋白沉积与各种疾病有关,特别是神经退行性疾病.
- 神经损伤功能障碍也与与年龄有关的病理有关.
- 粉症会影响眼部组织,需要与常见的老年眼病相关的研究.
研究的目的:
- 要总结当前对神经营养障碍和与年龄相关的黄斑变性 (AMD) 中的amyloidogenic过程的理解.
- 探索AMD和阿尔茨海默病 (AD) 中的氨基代和神经营养障碍的共享触发因素和相互贡献.
- 突出针对这两种机制的综合治疗策略的潜力.
主要方法:
- 关于粉样化症,神经营养障碍,AMD和AD的当前文献的综述.
- 粉样层级和神经营养障碍理论之间的相互作用的分析.
- 综合关于常见的致病机制和潜在的治疗点的证据.
主要成果:
- 氨基代和神经营养功能障碍与与年龄有关的神经退行性病理有关.
- 眼球粉样粉症呈现出各种表现,并与像AMD,白内障,绿内障和伪剥皮综合征这样的疾病有关.
- 氨基二代和神经营养障碍有共同的触发因素,并在AMD和AD中促进神经退行.
结论:
- 针对amyloidogenesis和神经质功能障碍的综合治疗策略可能有利于老年眼科疾病和AD患者.
- 需要进一步研究眼球氨基粉症和与年龄相关的眼睛疾病之间的联系.
- 了解共享的致病机制为改善患者生活质量提供了一个有希望的途径.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils
6.3K
6.3K
Alzheimer's Disease: Treatment
764
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
764
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K


